Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
Mateos, Maria-Victoria, Masszi, Tamas, Grzasko, Norbert, Hansson, Markus, Sandhu, Irwindeep, Pour, Ludek, Viterbo, Luísa, Jackson, Sharon R., Stoppa, Anne-Marie, Gimsing, Peter, Hamadani, Mehdi, BorsaLangue:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2017.170118
Date:
July, 2017
Fichier:
PDF, 773 KB
english, 2017